Safety and efficacy of outpatient gamma knife radiosurgery for multiple cerebral metastases

Expert Review of Neurotherapeutics

Volumn 4, Issue 4, 2004, Pages 673-679

  Wowra, Berndt ^a   Muacevic, Alexander ^b   Jess Hempen, Anja ^a   Tonn, Jörg Christian ^b  

^a Gamma Knife Center   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cerebral metastasis; Leksell gamma knife; Outpatient treatment; Radiosurgery

Indexed keywords

BRAIN HEMORRHAGE; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DIGESTIVE SYSTEM CANCER; GAMMA KNIFE RADIOSURGERY; HUMAN; KIDNEY CARCINOMA; LEKSELL GAMMA KNIFE; LINEAR ACCELERATOR; LUNG NON SMALL CELL CANCER; MELANOMA; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; OUTPATIENT CARE; PROGNOSIS; RADIATION DOSE; RADIOSURGERY; REVIEW; SAFETY; STEREOTAXIC SURGERY; WHOLE BRAIN RADIATION THERAPY;

EID: 3042739634     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.4.4.673     Document Type: Review

References (40)

1. Mehta MP, Boyd TS, Sinah P. The status of stereotactic radiosurgery for cerebral metastases in 1998. J. Radiosurg. 1, 17-30 (1998). Review of radiosurgery until 1998.
2. Shaw E, Scott C, Souhami L et al. Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of Radiation Therapy Oncology Group protocol 90-05. Int. J. Radiat. Oncol. Biol. Phys. 34, 647-654 (1996).
3. Hall WA, Djalilian HR, Nussbaum ES, Cho KH. Long-term survival with metastatic cancer to the brain. Med. Oncology 17, 279-286 (2000).
4. Schackert G, Steinmetz A, Meier U, Sobottka SB. Surgical management of single and multiple brain metastases: results of a retrospective study. Onkologie 24, 246-255 (2001).
5. Gaspar L, Scott C, Rotman M et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) Brain Metastases Trials. Int. J. Radiation Oncology Biol. Phys. 37, 745-751 (1997). Gives definition of prognostic factors that are widely accepted.
6. Buckner JC. The role of chemotherapy in the treatment of patients with brain metastases from solid tumors. Cancer Metastasis Rev. 10, 335-341 (1991).
7. Schackert G, Sobottka SB, Steinmetz A, Kirsch M. Current treatment strategies in brain metastases. Onkologie 23, 98-104 (2000). Summarizes the status of modern microsurgery for cerebral metastases (CM).
8. Soffietti R, Ruda R, Mutani R. Management of brain metastases. J. Neurol. 249, 1357-1369 (2002).
9. Sturm V, Kober B, Hover KH et al. Stereotactic percutaneous single dose irradiation of brain metastases with a linear accelerator. Int. J. Radiat. Oncol. Biol. Phys. 13, 279-282 (1987). First publication on radiosurgery (RS) for CM.
10. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir. Scand. 102, 316-319 (1951). First publication on RS for CM.
11. Yamamoto M. Gamma knife radiosurgery: technology, applications and future directions. Neurosurg. Clin. N. Am. 10, 181-202 (1999). Highlighting current technology in RS.
12. Schoggl A, Kitz K, Reddy M et al. Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir. 142, 621-626 (2000).
13. Simonova G, Liscak R, Novotny J Jr, Novotny J. Solitary brain metastases treated with the Leksell gamma knife: prognostic factors for patients. Radiother. Oncol. 57, 207-213 (2000).
14. Chen JC, Petrovich Z, Giannotta SL, Yu C, Apuzzo ML. Radiosurgical salvage therapy for patients presenting with recurrence of metastatic disease to the brain. Neurosurgery 46, 860-867 (2000).
15. Sneed PY, Lamborn KR, Forstrier JM et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int. J. Radiat. Oncol. Biol. Phys. 43, 549-558 (1999). Whole brain radiation therapy (WBRT) in the initial management of patients treated with RS for up to four CM is not required when allowing for salvage therapy.
16. Lavine SD, Petrovich Z, Cohen-Gadol AA et al. Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome and complications. Neurosurgery 44, 56-64 (1999).
17. Mori Y, Kondziolka D, Flickinger JC et al. Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int. J. Radiat. Oncol. Biol. Phys. 42, 581-589 (1998).
18. Mori Y, Kondziolka D, Flickinger JC, Logan T, Lunsford LD. Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer 83, 344-353 (1998).
19. Schoggl A, Kitz K, Ertl A et al. Gamma-knife radiosurgery for brain metastases of renal cell carcinoma: results in 23 patients. Acta Neurochir. 140, 549-555 (1998).
20. Kim YS, Kondziolka D, Flickinger JC, Lunsford LD. Stereotactic radiosurgery for patients with non-small cell lung carcinoma metastatic to the brain. Cancer 80, 2075-2083 (1997).
21. Flickinger JC, Kondziolka D, Lunsford LD et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int. J. Radiat. Oncol. Biol. Phys. 28, 797-802 (1994).
22. Gerosa M, Nicolato A, Severi F et al. Gamma knife radiosurgery for intracranial metastases: from local tumor control to increased survival. Stereotact. Funct. Neurosurg. 66, 184-192 (1996).
23. Chen JC, O'Day S, Morton D et al. Stereotactic radiosurgery in the treatment of metastatic disease to the brain. Stereotact. Funct. Neurosurg. 73, 60-63 (1999).
24. Muacevic A, Kreth FW. Horstmann GA et al. Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J. Neurosurg. 91, 35-43 (1999). Retrospective study showing that RS is not inferior to surgery and WBRT for control of solitary CM.
25. Mack A, Czempiel H, Kreiner HJ, Durr G, Wowra B. Quality assurance in stereotactic space. A system test for verifying the accuracy of aim in radiosurgery. Med. Phys. 29, 561-568 (2002).
26. Wowra B. Radiochirurgie intrakranieller Prozesse. Nervenheilkunde 18, 238-245 (1999).
27. Wowra B, Siebels M, Muacevic A et al. Repeated gamma knife surgery for multiple brain metastases from renal cell carcinoma. J. Neurosurg. 97, 785-793 (2002). Largest specific study of RS for multiple CM of renal cancer.
28. Wowra B, Czempiel H, Cibis R, Horstmann GA. Profile of ambulatory radiosurgery with the gamma knife system. 1: method and multicenter irradiation concept. Radiologe 37, 995-1002 (1997).
29. Voges J, Treuer H, Sturm V et al. Risk analysis of linear accelerator radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 36, 1055-1063 (1996).
30. Chidel MA, Suh JH, Reddy CA et al. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 47, 993-999 (2000).
31. Niibe Y, Karasawa K, Nakamura O et al. Survival benefit of stereotactic radiosurgery for metastatic brain tumors in patients with controlled primary lesions and no other distant metastases. AntiCancer Res. 23, 4157-4159 (2003). RS for CM does have a survival benefit in patients with controlled primary lesions and no other distant metastases. These patients should not be treated with palliative intent but pursue longer survival.
32. Gerosa M, Nicolato A, Foroni R et al. Gamma knife radiosurgery for brain metastases: a primary therapeutic option. J. Neurosurg. 97, 515-524 (2002).
33. Wowra B, Horstmann GA, Cibis R, Czempiel H. Profile of ambulatory radiosurgery with the gamma knife system. 2: report of clinical experiences. Radiologe 37, 1003-1015 (1997).
34. Amendola BE, Wolf AL, Coy SR, Amendola M, Bloch L. Brain metastases in renal cell carcinoma: management with gamma knife radiosurgery. Cancer J. 6, 372-376 (2000).
35. Amendola BE, Wolf AL, Coy SR, Amendola M, Bloch L. Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast. Cancer J. 6, 88-92 (2000).
36. Petrovich Z, Yu C, Giannotta SL, O'Day S, Apuzzo ML. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J. Neurosurg. 97, 499-506 (2002).
37. Engenhart R, Kimmig BN, Hover KH et al. Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 71, 1353-1361 (1993).
38. Chidel MA, Suh JH, Greskovich JF, Kupelian PA, Barnett GH. Treatment outcome for patients with primary non-small cell lung cancer and synchronous brain metastasis. Radiat. Oncol. Investig. 7, 313-319 (1999).
39. Young RF. Radiosurgery for the treatment of brain metastases. Semin. Surg. Oncol. 14, 70-78 (1998).
40. Sneed PK, Suh JH, Goetsch SJ et al. A multi-institutional review of radiosurgery alone versus radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 53, 519-526 (2002). Large multi-institutional study showing that the omission of up-front WBRT does not appear to compromise the length of survival in patients treated with RS for newly diagnosed brain metastases.